Velarion Records
Free. Unsubscribe any time.

Immunome Inc. (IMNM)

Immunome Inc. filed 13 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 5 reporting owners, covering 24 transactions and 1,153,148 shares. None carries the SEC's AFF10B5ONE flag; all 13 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Immunome Inc. 24

Adoption dates in Immunome Inc. 6

Results prints in Immunome Inc. 0

Trades before a print in Immunome Inc. 0

Interval to Immunome Inc.’s next reported results date

How the interval and sources are counted →

Adoption dates Immunome Inc. states

Filing text: “10b5-1 trading plan adopted by the Reporting Person on May 23, 2024”

Sources: SEC EDGAR full-text search and the SEC submissions API.